Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Recent Trends on the Role of Epigenomics, Metabolomics and Noncoding RNAs in Rationalizing Mood Stabilizing Treatment

4 Dec 2017

Abstract excerpt

Mood stabilizers are the cornerstone in treatment of mood disorders, but their use is characterized by high interindividual variability. This feature has stimulated intensive research to identify predictive biomarkers of response and disentangle the molecular bases of their clinical efficacy. Nevertheless, findings from studies conducted so far have only explained a small proportion of the observed variability,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent and Pediatric Healthcare
Share to Bipolar Disorder and Treatment
Share to Tryptophan and brain disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29199496
DOI: 10.2217/pgs-2017-0111

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Recent Trends on the Role of Epigenomics, Metabolomics and Noncoding RNAs in Rationalizing Mood Stabilizing TreatmentPMID 29199496Read ↗

Understanding the molecular mechanisms underlying mood stabilizer treatments in bipolar disorder: Potential involvement of epigeneticsSemantic proximity Read ↗

Molecular Signatures of Lithium Treatment: Current KnowledgeSemantic proximity Read ↗

Genetic and Epigenetic Markers of Lithium ResponseSemantic proximity Read ↗

Genetics and Antiepileptic Mood Stabilizer Treatment Response in Bipolar Disorder: What do we Know?Semantic proximity Read ↗

Lithium Pharmacogenetics: Where Do We Stand?Semantic proximity Read ↗

Pharmacogenomics of Bipolar DisorderSemantic proximity Read ↗

Epigenetic Modulation of Mood DisordersSemantic proximity Read ↗

Pharmacogenomic aspects of bipolar disorder: An updateSemantic proximity Read ↗

Effect of mood stabilizers on DNA methylation in human neuroblastoma cellsSemantic proximity Read ↗

[MicroRNAs in bipolar disorder: diagnostic and therapeutic applications].Semantic proximity Read ↗

Lithium response in bipolar disorder: Genetics, genomics, and beyondSemantic proximity Read ↗

DNA Methylation Signatures of Mood Stabilizers and Antipsychotics in Bipolar DisorderSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.